Dual anti-platelet therapy with with clopidogrel or prasugrel patients at a risk of very late stent thrombosis

Trial Profile

Dual anti-platelet therapy with with clopidogrel or prasugrel patients at a risk of very late stent thrombosis

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Oct 2016

At a glance

  • Drugs Clopidogrel (Primary) ; Prasugrel (Primary) ; Aspirin
  • Indications Acute coronary syndromes
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 07 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top